HFE gene mutations in Brazilian thalassemic patients

dc.contributor.authorOliveira, T. M.
dc.contributor.authorSouza, F. P.
dc.contributor.authorJardim, A. C. G.
dc.contributor.authorCordeiro, J. A.
dc.contributor.authorPinho, J. R. R.
dc.contributor.authorSitnik, R.
dc.contributor.authorEstevão, J. F.
dc.contributor.authorBonini-Domingos, C. R.
dc.contributor.authorRahal, Paula [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionFaculdade de Medicina de São José do Rio Preto (FAMERP)
dc.contributor.institutionHospital Israelita Albert Einstein
dc.date.accessioned2014-05-27T11:22:04Z
dc.date.available2014-05-27T11:22:04Z
dc.date.issued2006-12-01
dc.description.abstractHereditary hemochromatosis is a disorder of iron metabolism characterized by increased iron intake and progressive storage and is related to mutations in the HFE gene. Interactions between thalassemia and hemochromatosis may further increase iron overload. The ethnic background of the Brazilian population is heterogeneous and studies analyzing the simultaneous presence of HFE and thalassemia-related mutations have not been carried out. The aim of this study was to evaluate the prevalence of the H63D, S65C and C282Y mutations in the HFE gene among 102 individuals with alpha-thalassemia and 168 beta-thalassemia heterozygotes and to compare them with 173 control individuals without hemoglobinopathies. The allelic frequencies found in these three groups were 0.98, 2.38, and 0.29% for the C282Y mutation, 13.72, 13.70, and 9.54% for the H63D mutation, and 0, 0.60, and 0.87% for the S65C mutation, respectively. The chi-square test for multiple independent individuals indicated a significant difference among groups for the C282Y mutation, which was shown to be significant between the beta-thalassemia heterozygote and the control group by the Fisher exact test (P value = 0.009). The higher frequency of inheritance of the C282Y mutation in the HFE gene among beta-thalassemic patients may contribute to worsen the clinical picture of these individuals. In view of the characteristics of the Brazilian population, the present results emphasize the need to screen for HFE mutations in beta-thalassemia carriers.en
dc.description.affiliationDepartamento de Biologia Instituto de Biociências Universidade do Estado de São Paulo, 15054-000 Sao Jose do Rio Preto, SP
dc.description.affiliationDepartamento de Microbiologia Instituto de Ciências Biomédicas Universidade de São Paulo, São Paulo, SP
dc.description.affiliationDepartamento de Gastroenterologia Faculdade de Medicina Universidade de São Paulo, São Paulo, SP
dc.description.affiliationDepartamento de Saúde Coletiva e Epidemiologia Faculdade de Medicina de São Jose do Rio Preto, Sao Jose do Rio Preto, SP
dc.description.affiliationDepartamento de Patologia Clínica Hospital Israelita Albert Einstein, São Paulo, SP
dc.format.extent1575-1580
dc.identifierhttp://dx.doi.org/10.1590/S0100-879X2006001200008
dc.identifierhttp://dx.doi.org/10.1590/S0100-879X2006005000041
dc.identifier.citationBrazilian Journal of Medical and Biological Research, v. 39, n. 12, p. 1575-1580, 2006.
dc.identifier.doi10.1590/S0100-879X2006001200008
dc.identifier.file2-s2.0-33847656226.pdf
dc.identifier.issn0100-879X
dc.identifier.issn1678-4510
dc.identifier.lattes7991082362671212
dc.identifier.lattes3279428066176719
dc.identifier.orcid0000-0001-5693-6148
dc.identifier.orcid0000-0002-4603-9467
dc.identifier.scieloS0100-879X2006001200008
dc.identifier.scopus2-s2.0-33847656226
dc.identifier.urihttp://hdl.handle.net/11449/69283
dc.identifier.wosWOS:000243103300008
dc.language.isoeng
dc.relation.ispartofBrazilian Journal of Medical and Biological Research
dc.relation.ispartofjcr1.492
dc.rights.accessRightsAcesso aberto
dc.sourceScopus
dc.subjectC282Y
dc.subjectH63D
dc.subjectHFE
dc.subjectS65C
dc.subjectThalassemia
dc.subjectHFE protein
dc.subjectalpha thalassemia
dc.subjectbeta thalassemia
dc.subjectBrazil
dc.subjectchi square test
dc.subjectclinical feature
dc.subjectcontrolled study
dc.subjectfemale
dc.subjectFisher exact test
dc.subjectgene frequency
dc.subjectgene mutation
dc.subjecthemoglobinopathy
dc.subjectheterozygote
dc.subjecthuman
dc.subjectinheritance
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectprevalence
dc.subjectthalassemia
dc.subjectalpha-Thalassemia
dc.subjectbeta-Thalassemia
dc.subjectCase-Control Studies
dc.subjectFemale
dc.subjectGene Frequency
dc.subjectGenotype
dc.subjectHeterozygote
dc.subjectHistocompatibility Antigens Class I
dc.subjectHumans
dc.subjectMale
dc.subjectMembrane Proteins
dc.subjectMutation
dc.subjectPolymerase Chain Reaction
dc.titleHFE gene mutations in Brazilian thalassemic patientsen
dc.typeArtigo
dcterms.licensehttp://www.scielo.br/revistas/bjmbr/iaboutj.htm
unesp.author.lattes7991082362671212[9]
unesp.author.lattes3279428066176719[8]
unesp.author.orcid0000-0002-6243-8118[6]
unesp.author.orcid0000-0002-6348-7923[3]
unesp.author.orcid0000-0003-3999-0489[5]
unesp.author.orcid0000-0002-4603-9467[8]
unesp.author.orcid0000-0001-5693-6148[9]
unesp.campusUniversidade Estadual Paulista (Unesp), Instituto de Biociências Letras e Ciências Exatas, São José do Rio Pretopt
unesp.departmentBiologia - IBILCEpt

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
2-s2.0-33847656226.pdf
Tamanho:
453.06 KB
Formato:
Adobe Portable Document Format